News

Monoclonal Antibody Drugs for Cancer Treatment

Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.

Monday, December 1, 2008
Kathryn Anderson
Kathryn Anderson Elected to the Institute of Medicine

Kathryn V. Anderson has been elected a member of the Institute of Medicine of the National Academies.

Monday, December 1, 2008
Harold Varmus
Harold Varmus Awarded Henry G. Friesen International Prize in Health Research

Memorial Sloan Kettering Cancer Center President Harold Varmus was awarded the 2008 Henry G. Friesen International Prize in Health Research on September 24 in Toronto.

Monday, December 1, 2008
Charles Sawyers
Charles Sawyers Elected to the Institute of Medicine

Charles L. Sawyers has been elected a member of the Institute of Medicine of the National Academies.

Monday, December 1, 2008
New Geoffrey Beene Gift to Memorial Sloan Kettering Puts Total Support Over $100 Million

Memorial Sloan Kettering Cancer Center has announced the gift of a membership interest in Geoffrey Beene, LLC, the company that controls the business and fashion empire created by legendary designer Geoffrey Beene.

Thursday, October 9, 2008
Michael Glickman
An Interview with Michael Glickman

Physician-scientist Michael S. Glickman specializes in the treatment and study of infectious diseases.

Wednesday, October 1, 2008
Genetic Information Becomes a Vital Part of Clinical Practice

At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.

Wednesday, October 1, 2008
Scott N. Keeney
Scott Keeney Selected as a Howard Hughes Medical Institute Investigator

Scott N. Keeney, a member of the Molecular Biology Program within the Sloan Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute (HHMI) investigator in 2008.

Wednesday, October 1, 2008
Thomas Kelly Named to Advisory Committee at National Institutes of Health

Sloan Kettering Institute Director Thomas J. Kelly has been named a member of the Advisory Committee to the Director (ACD) at the National Institutes of Health.

Thursday, May 15, 2008
Researchers Learn How Signaling Molecule Orchestrates Breast Cancer's Spread

A study led by researchers at Memorial Sloan Kettering Cancer Center has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells.

Thursday, April 3, 2008